Method for preparing injectable diabetic osteochondral repair hydrogel containing V2CuS4 nano-enzyme based on hydrothermal method and application of injectable diabetic osteochondral repair hydrogel
The preparation of V2CuS4 nanozymes and photogelled silk fibroin hydrogels via hydrothermal method solved the problems of decoupling of antioxidant and osteogenic functions and material instability in diabetic osteochondral defects. It achieved efficient scavenging of reactive oxygen species and promotion of bone mineralization, and has good biocompatibility and structural stability.
Patent Information
- Application Number
- CN202511504301.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-10-21
- Publication Date
- 2026-01-20
- Estimated Expiration
- 2045-10-21
AI Technical Summary
Existing biomaterials suffer from low antioxidant-osteogenic decoupling, metal ion toxicity, and catalytic efficiency in diabetic osteochondral defects. Defects in the synthesis of traditional nanozymes limit their clearance efficiency, and hydrogels are structurally unstable in high-sugar environments, failing to effectively alleviate oxidative stress damage.
V2CuS4 nanozymes were prepared by hydrothermal method, and combined with glucose oxidase and methacrylamide silk fibroin to construct a cascade reaction system, forming a photogelled injectable hydrogel, which achieves reactive oxygen species scavenging and mechanical stability.
In a simulated diabetic microenvironment, the hydrogel exhibits high scavenging rates of hydroxyl radicals and superoxide anions, significantly improves oxidative stress, promotes bone mineralization, and demonstrates good biocompatibility and structural stability.
Smart Images

Figure FT_1 
Figure FT_2 
Figure FT_3
Abstract
Description
TECHNICAL FIELD
[0001] The present application relates to the technical field of biomedical materials and tissue engineering, and particularly relates to a method for preparing injectable sugar diabetes bone cartilage repair hydrogel containing V2CuS4 nanoscale enzyme based on a hydrothermal method and application thereof. BACKGROUND
[0002] In the pathological microenvironment of diabetic bone cartilage defects, long-term hyperglycemia can trigger a series of oxidative stress reactions, which directly damage the mitochondrial function of osteoblasts, leading to a significant decrease in mitochondrial membrane potential (possibly below 48.7 mV, far below the 120 mV threshold required for normal function), which is a core pathological mechanism that hinders bone matrix mineralization.
[0003] The existing biomaterial system for bone cartilage repair mainly includes bioactive materials and metal-based antioxidant materials. Among them, bioactive materials such as silicate bioactive glass, such as 45S5 series, have excellent in vitro bone induction ability (hydroxyapatite deposition rate is more than 3 μm / d), but in the simulated diabetic high glucose environment (10 mM glucose), its efficiency of scavenging hydroxyl radicals and other active oxygen is less than 35%, which is difficult to alleviate pathological level of oxidative stress damage. Metal-based antioxidant materials such as some metal organic frameworks MOFs face another problem. Although they can regulate the level of active oxygen by simulating the Fenton reaction, the released metal ions (such as Fe 2+ and Cu 2+ ) often lack controllability, and excessive release of metal ions can cause abnormal increase of lysosome membrane permeability (LMP value is more than 60%) of osteoblasts, and then induce cell apoptosis of more than 78%, which seriously inhibits osteogenic activity.
[0004] The regulation of nanoscale enzyme activity is generally through high-temperature solvothermal method (>200℃) to synthesize ternary sulfide (such as CuFeS2), which has high crystal defect density (transmission electron microscopy shows that dislocation is dense) due to thermodynamic imbalance, and limited specific surface area (<80m 2 / g), which significantly reduces its peroxidase-like (POD) activity (only 2.1 U / mg). Such defects directly weaken the scavenging efficiency of nanoscale enzyme on active oxygen, which is difficult to meet the intervention needs of strong oxidative stress in diabetic high glucose microenvironment. When constructing a multi-stage reaction system, the spatial separation of glucose oxidase (GOx) and nanoscale enzyme is too large (distance > 50 nm), which leads to a high diffusion loss rate of H2O2 of 78%, which seriously restricts the reaction efficiency. The physical mixing system lacks spatial confinement regulation, and cannot realize the directional transfer of substrates, resulting in the catalytic kinetic constant stagnating at 1.6×103M -1 s -1 Therefore, it is difficult to match the rapid response needs in diabetic microenvironment.
[0005] In the current technical system, bioactive glass, MOFs and other materials have low bone integration rate due to the decoupling of antioxidant-osteogenic function and metal ion toxicity; traditional ternary sulfide nanometer enzymes have limited catalytic efficiency due to defects caused by high-temperature synthesis, and the process such as wet spinning is difficult to realize uniform compounding of enzymes-nanometer enzymes; traditional injectable hydrogel shows significant volume swelling control (change rate > 300%) in the diabetic high glucose-serum combined microenvironment, and the active oxygen scavenging half-life is short (< 24h), and the mechanical stability and antioxidant durability are insufficient, which leads to the collapse of the material structure after implantation and the rapid loss of active ingredients, and cannot maintain the regulation of long-term pathological microenvironment. Therefore, it has important clinical transformation value to develop new materials with structural stability, synergistic antioxidant and bone mineralization ability. SUMMARY
[0006] In order to solve the problem of poor antioxidant-osteogenic function of materials in diabetic bone regeneration technology, the application provides a method for preparing injectable diabetic osteochondral repair hydrogel containing V2CuS4 nanometer enzyme based on hydrothermal method and its application. The application innovatively develops an injectable hydrogel with active oxygen scavenging (hydroxyl radical removal rate ≥ 95%) and mechanical stability by controllable synthesis of V2CuS4 nanometer enzyme by hydrothermal method, mixing at room temperature to construct a cascade reaction system, and combining the characteristics of photogelation of methacrylamidated silk fibroin hydrogel.
[0007] The method for preparing active oxygen scavenging type diabetic osteochondral repair hydrogel based on hydrothermal method provided by the application comprises the following steps: (1) copper salt, vanadium salt and sulfur source are mixed and dissolved in water, and after hydrothermal reaction, centrifugation, washing and drying, V2CuS4 nanometer enzyme is obtained.
[0008] (2) the glucose oxidase and the V2CuS4 nanometer enzyme are uniformly mixed to obtain an enzyme mixture, the methacrylamidated silk fibroin protein is added to the enzyme mixture to obtain a mixed solution, the photoinitiator is added to the mixed solution to obtain a composite material aqueous solution, and the composite material aqueous solution is ultrasonically dispersed to form an injectable three-dimensional network hydrogel with photogelation characteristics.
[0009] Preferably, the copper salt in step (1) is one of copper chloride, copper nitrate and copper sulfate; the vanadium salt is one of vanadyl sulfate, sodium vanadate and vanadium oxide; and the sulfur source is one of sodium thiosulfate, thiourea and sulfur powder.
[0010] Preferably, in step (1), the stoichiometric ratio of Cu:V:S in the copper salt, vanadium salt and sulfur source is 1:2:4-8.
[0011] Preferably, the hydrothermal reaction vessel in step (1) of the present application is a high-pressure reaction kettle with a polytetrafluoroethylene lining; and the hydrothermal reaction conditions are constant temperature treatment at 120-180℃ for 12-24h.
[0012] Preferably, the centrifugation parameters in step (1) of the present application are 2000-6000rpm for 10-30 minutes.
[0013] Preferably, the washing in step (1) of the present application is performed three times alternately using anhydrous ethanol and deionized water.
[0014] Preferably, the vacuum drying conditions in step (1) of the present application are 40-60℃, -0.2 to -0.8MPa for 6-18h.
[0015] Preferably, the particle size of the V2CuS4 nanoscale enzyme in step (1) of the present application is 20-50nm, and the specific surface area is ≥80m 2 / g.
[0016] Preferably, the activity of glucose oxidase in step (2) of the present application is ≥150U / mg.
[0017] Preferably, the mass ratio of glucose oxidase to V2CuS4 nanoscale enzyme in the enzyme mixture in step (2) of the present application is 1:1-5; the mass ratio of the enzyme mixture to methylacrylamidated silk fibroin in the mixed solution is 1:80-100; and the mass percentage of the mixed solution to the photoinitiator in the composite aqueous solution is 1:0.05-0.2%.
[0018] Preferably, the ultrasonic dispersion parameters in step (2) are 20-60kHz, 30-70W / cm 2 , for 5-15 minutes at a mixing temperature of 15-30℃, and the obtained hydrogel can complete gelation under a 405nm ultraviolet lamp for 20-45s.
[0019] The hydrogel prepared by the method of the present application can be applied to a diabetic osteochondral repair material, specifically, the hydrogel is loaded into an osteochondral repair scaffold material to form a diabetic bone repair material with active oxygen scavenging function.
[0020] Under the simulated diabetic microenvironment (glucose concentration of 10mM and H2O2 concentration of 100-500μM), the scavenging rate of the hydrogel to hydroxyl radicals is ≥95%, and the scavenging rate to superoxide anion is ≥85%.
[0021] The degummed cocoon is dissolved by Ajisawa system or LiBr system to obtain silk fibroin; the silk fibroin is amidated by using methacrylic anhydride or glycidyl methacrylate; the photoinitiation functional group is introduced into the silk fibroin molecular chain by using a photoinitiator 2959 [2-hydroxy-4'-(2-hydroxyethoxy)-2-methylpropiophenone] or LAP [phenyl (2,4,6-trimethylbenzoyl) lithium phosphate salt], and the photoinitiation gelation of the methacrylamidated silk fibroin is realized.
[0022] Mechanism of the application: the application repairs diabetic osteochondral by integrating silk fibroin-based photoinitiation hydrogel and GOx-V2CuS4-mediated cascade reaction, the hydrogel prepared by the application can remove active oxygen while decomposing glucose, the GOx-V2CuS4-mediated cascade reaction continuously provides microbial support required for tissue repair, significantly inhibits the accumulation of diabetic glycosylation end products (AGEs), significantly improves the oxidative stress microenvironment by efficiently removing active oxygen, the application improves the bone mineralization ability while synergistically resisting oxidation, which is beneficial to bone matrix regeneration and mineralization.
[0023] Beneficial effects of the application: The application breaks through the limitations of traditional single antioxidant or metal nanoparticles, the V2CuS4 nanoscale enzyme constructed by the hydrothermal method is uniformly dispersed, has peroxidase-like activity and stability, can stably remove active oxygen produced in the glucose degradation process and in the cascade reaction, and significantly improves the oxidative stress diabetic bone defect microenvironment. The cascade reaction system formed by the application overcomes the defects of low removal efficiency and short action period of traditional antioxidant materials.
[0024] The application adopts the idea of normal temperature mixing and photogelation, avoids the damage of high temperature treatment to enzyme activity, simultaneously realizes the in-situ formation of injectable gel by using the characteristics of silk fibroin photogelation, and has good biocompatibility. Compared with traditional chemical crosslinking hydrogel, the process significantly improves the retention rate of bioactive ingredients, and accurately matches the precise filling of bone and cartilage defect sites with individual differences and time sequence differences. BRIEF DESCRIPTION OF DRAWINGS
[0025] Figure 1 is the SEM morphology analysis of V2CuS4 nanoscale enzyme synthesized in example 1 of the application.
[0026] Figure 2 is the XRD pattern of V2CuS4 nanoscale enzyme synthesized in example 1 of the application.
[0027] Figure 3is the V2CuS4 nanoscale peroxidase activity verification based on the TMB color reaction of the embodiment 1 of the present application.
[0028] Figure 4 is the light-induced gelation performance of the V2CuS4-GOx-methacrylamide silk fibroin hydrogel cascade reaction system prepared in the embodiment 1 of the present application.
[0029] Figure 5 is the biocompatibility verification of the V2CuS4-GOx-methacrylamide silk fibroin hydrogel prepared in the embodiment 1 of the present application.
[0030] Figure 6 is the schematic diagram of the application mode of the hydrogel of the present application to bone cartilage. DETAILED DESCRIPTION
[0031] The present application will be further described in conjunction with the drawings and specific embodiments, but the scope of protection of the present application is not limited to the content described.
[0032] Copper salts include copper nitrate (Cu(NO3)2·3H2O), copper chloride (CuCl2) and copper sulfate (Cu2SO4); vanadium salts include vanadyl sulfate (VOSO4·2H2O), sodium vanadate (Na3VO4) and vanadium oxide (V2O5); thiourea (CH4N2S) in sulfur source; anhydrous calcium chloride (CaCl2); methacrylic anhydride. The above reagents are purchased from China Aladdin, purity ≥ 99.0%.
[0033] Sodium thiosulfate (Na2S2O3, purity ≥ 99.0%); anhydrous ethanol, hydrogen peroxide (H2O2, concentration 3wt%), 3,3',5,5'-tetramethylbenzidine (TMB), glucose oxidase (GOx, activity ≥ 100 U / mg 3 ), purity ≥ 99.0%, methacrylic anhydride (Methacrylic Anhydride), purity 94%, containing 0.2% topanol stabilizer. The above reagents are all purchased from Luo En.
[0034] Photoinitiator 2959 [2-hydroxy-4'-(2-hydroxyethoxy)-2-methylpropiophenone] and photoinitiator LAP [lithium salt of phenyl (2,4,6-trimethylbenzoyl) phosphate]; a dialysis bag of 14 kDa is purchased from Solarbio, USA. Sulfur powder (GSB0417732004) is purchased from the Nonferrous Institute, purity ≥ 99.0%.
[0035] The preparation of methacrylamidated silk fibroin is as follows: Mix 2 g degummed silk fibroin, 8 mL water, 350 mM methyl methacrylate (0.5395 g) uniformly, heat to 60℃, stir at 300 rpm for 3 h, use a 14 kDa dialysis bag to dialyze at 25℃ for 72 h to remove unreacted methyl methacrylate, and obtain methyl methacrylamidated silk fibroin. Example 1
[0036] A method for preparing an active oxygen scavenging type diabetic bone repair hydrogel based on a hydrothermal method, the specific steps are as follows: (1) Dissolve copper nitrate (Cu(NO3)2·3H2O), vanadyl sulfate (VOSO4·2H2O) and thiourea (CH4N2S) in 30 mL of deionized water according to the stoichiometric ratio of Cu:V:S as 1:2:4, stir until completely dissolved, and form a dark blue-gray precipitate.
[0037] (2) Transfer the dark blue-gray precipitate in (1) to a polytetrafluoroethylene-lined high-pressure reaction kettle (volume 100 mL, filling rate 40%), and react at 120℃ for 12 h under constant temperature conditions.
[0038] (3) The product after the reaction in (2) is naturally cooled to room temperature, centrifuged at 3000 rpm for 10 minutes to separate the product, and washed with anhydrous ethanol and deionized water alternately for 3 times (10 minutes each time).
[0039] (4) The washed and separated product in (3) is dried at 40℃ under a vacuum of -0.2 MPa for 12 h to obtain V2CuS4 nanoscale enzyme powder.
[0040] (5) Mix the glucose oxidase and V2CuS4 nanoscale enzyme uniformly according to a mass ratio of 1:1 to obtain an enzyme mixture, add methyl methacrylamidated silk fibroin according to a mass ratio of 1:80 between the enzyme mixture and the methyl methacrylamidated silk fibroin to obtain a mixed solution, add a photoinitiator according to a mass percentage of 1:0.05% in the mixed solution to obtain a composite material aqueous solution, and magnetically stir at 15℃ for 12 h until completely dissolved to obtain an 8wt% composite material aqueous solution.
[0041] (6) The composite material aqueous solution obtained in (5) is ultrasonically dispersed at 25℃ at a frequency of 20 kHz and a power density of 30 W / cm 2 to form an injectable three-dimensional network hydrogel with light-induced gelation characteristics, and the gelation time is 30 s. Example 2
[0042] A method for preparing an active oxygen scavenging type diabetic bone repair hydrogel based on a hydrothermal method, the specific steps are as follows: (1) Copper nitrate (Cu(NO3)2·3H2O), sodium vanadate (Na3VO4) and thiourea (CH4N2S) were dissolved in 20 mL of deionized water in a stoichiometric ratio of Cu:V:S of 1:2:6, stirred until completely dissolved, and a dark gray-blue precipitate was formed.
[0043] (2) The dark brown precipitate in (1) was transferred to a polytetrafluoroethylene-lined high-pressure reaction kettle (volume 100 mL, filling rate 40%), and reacted at 180°C for 24 h under constant temperature conditions.
[0044] (3) The product after reaction in (2) was naturally cooled to room temperature, centrifuged at 6000 rpm for 20 minutes to separate the product, and washed with anhydrous ethanol and deionized water alternately for 3 times (10 minutes each time).
[0045] (4) The washed and separated product in (3) was dried at 60°C under a vacuum of -0.8 MPa for 18 h to obtain V2CuS4 nanometer enzyme powder.
[0046] (5) The enzyme mixture was obtained by uniformly mixing glucose oxidase and V2CuS4 nanometer enzyme in a mass ratio of 1:5, and the methacrylamidated silk fibroin was added in a mass ratio of 1:100 to the enzyme mixture to obtain a mixed solution, and the photoinitiator was added in a mass ratio of 1:0.2% to the mixed solution to obtain a composite material aqueous solution. The composite material aqueous solution obtained in (5) was magnetically stirred at 20°C for 12 h until completely dissolved to obtain a 12wt% composite material aqueous solution.
[0047] (6) The composite material aqueous solution obtained in (5) was ultrasonically dispersed at a frequency of 60 kHz and a power density of 70 W / cm 2 for 5 minutes under the condition of 20°C to form an injectable three-dimensional network hydrogel with photo-induced gelation characteristics, and the gelation time was 20 s. Example 3
[0048] A method for preparing an active oxygen scavenging type diabetic bone repair hydrogel based on a hydrothermal method, the specific steps are as follows: (1) Copper nitrate (Cu(NO3)2·3H2O), vanadium oxide (V2O5) and thiourea (CH4N2S) were dissolved in 30 mL of deionized water in a stoichiometric ratio of Cu:V:S of 1:2:8, stirred until completely dissolved, and a dark gray-blue precipitate was formed.
[0049] (2) The dark brown precipitate in (1) was transferred to a polytetrafluoroethylene-lined high-pressure reaction kettle (volume 100 mL, filling rate 40%), and reacted at 160°C for 18 h under constant temperature conditions.
[0050] (3) The product after the reaction in (2) is naturally cooled to room temperature, and the product is separated by centrifugation at 4000 rpm for 30 minutes, and washed with anhydrous ethanol and deionized water alternately for 3 times (10 minutes each time).
[0051] (4) The washed and separated product in (3) is dried at 50°C under a vacuum condition of -0.5 MPa for 12 h to obtain a V2CuS4 nanoscale enzyme powder.
[0052] (5) The enzyme mixture is obtained by uniformly mixing glucose oxidase and V2CuS4 nanoscale enzyme at a mass ratio of 1:3, the mixed solution is obtained by adding methacrylamidated silk fibroin at a mass ratio of 1:90 of the enzyme mixture and the methacrylamidated silk fibroin, and the composite material aqueous solution is obtained by adding a photoinitiator at a mass percentage of 1:0.1% of the mixed solution, and the composite material aqueous solution is obtained by magnetic stirring at 25°C for 12 h until complete dissolution, and the composite material aqueous solution is obtained.
[0053] (6) The composite material dispersion solution obtained in (5) is ultrasonically dispersed at a frequency of 40 kHz and a power density of 50 W / cm 2 for 15 minutes at 15°C to form an injectable three-dimensional network hydrogel with a light-induced gelation property, and the gelation time is 45 s. Example 4
[0054] A method for preparing an active oxygen scavenging type diabetes bone repair hydrogel based on a hydrothermal method, and the specific steps are as follows: (1) Copper chloride (CuCl2), vanadyl sulfate (VOSO4·2H2O) and sodium thiosulfate (Na2S2O3) are dissolved in 20 mL of deionized water at a Cu:V:S stoichiometric ratio of 2:1:4, stirred until completely dissolved, and a dark blue precipitate is formed.
[0055] (2) The dark brown precipitate in (1) is transferred to a polytetrafluoroethylene-lined high-pressure reaction kettle (volume 100 mL, filling rate 40%), and reacted at 140°C under constant temperature conditions for 18 h.
[0056] (3) The product after the reaction in (2) is naturally cooled to room temperature, and the product is separated by centrifugation at 2000 rpm for 20 minutes, and washed with anhydrous ethanol and deionized water alternately for 3 times (10 minutes each time).
[0057] (4) The washed and separated product in (3) is dried at 50°C under a vacuum condition of -0.5 MPa for 6 h to obtain a V2CuS4 nanoscale enzyme powder.
[0058] (5) Mix glucose oxidase and V2CuS4 nanozyme at a mass ratio of 1:3 to obtain an enzyme mixture. Add methacrylamide silk fibroin at a mass ratio of 1:100 to obtain a mixed solution. Add photoinitiator at a mass percentage of 1:0.05% to obtain an aqueous solution of composite material. Stir magnetically at 30°C for 12 hours until completely dissolved to obtain a 10wt% aqueous solution of composite material.
[0059] (6) The composite material dispersion obtained in (5) is subjected to a temperature of 30°C and a frequency of 40kHz and a concentration of 50W / cm. 2 Power density ultrasonic dispersion for 10 minutes forms an injectable three-dimensional network hydrogel with photo-initiated gelation properties, with a gelation time of 40 seconds.
[0060] Performance testing: 1. Morphological characteristics of V2CuS4 nanozymes The V2CuS4 nanozyme prepared in Example 1 was subjected to SEM at an accelerating voltage of 5-20 kV and a resolution of <5 nm, as shown in the figure. Figure 1 As shown in AB, the nanozymes exhibit uniform, spherical particle shapes. EDS-Mapping results indicate that the vanadium, copper, and sulfur elements in the nanozymes are relatively evenly distributed on the surface. Figure 1 C), X-ray diffraction (XRD) was used to characterize the crystal structure of the V2CuS4 nanozyme, using Cu-Kα rays (λ=1.5406 Å), with a scan range of 10°–80° (2θ) and a step size of 0.02°. The results showed that the V2CuS4 nanozyme was in high agreement with the theoretical simulation parameters. Figure 2 This confirms the effectiveness of the synthesis method. Figure 1 The proportions of Cu, V, and S in the hydrogel, as indicated by the amount of substance added, may differ from the actual surface atomic distribution. This is because the sensitivity to light elements such as S is relatively low, resulting in smaller observed values, which is reasonable. 2. In vitro hydrogen peroxide decomposition experiment of V2CuS4 nanozyme The V2CuS4 nanozyme prepared in Example 1 exhibited significant peroxidase-like activity under physiological conditions, such as... Figure 3 As shown, a 200 μL reaction system (16 mM TMB (3,3',5,5'-tetramethylbenzidine), 1 M H₂O₂, 0.2 M acetate buffer (pH 4.0), 300 μg / mL V₂CuS₄ nanozyme) was constructed during the assay, and the enzyme activity of the V₂CuS₄ nanozyme was calculated according to the following formula: ; in : Rate of change of absorbance : Reaction volume (mL) : Molar extinction coefficient of TMB oxidation product (39,000 M⁻¹cm⁻¹), d: Cuvette path length (cm). Enzyme mass (mg).
[0061] 3. Rheological experiments on injectable diabetic osteochondral repair hydrogel containing V2CuS4 nanozyme like Figure 4 As shown, the rheological tests were conducted at 18-30℃ with shear rates ranging from 0.1 to 100 s⁻¹. -1 The viscosity changes were recorded, and the injectability was evaluated (the viscosity was considered extrudable when it dropped to <10 Pa·s). The viscosity with both storage modulus and loss modulus at gelation was <10 Pa·s, which verified the photogelation properties and extrudability of the hydrogel prepared in Example 1.
[0062] 4. Hemolysis experiment of injectable diabetic osteochondral repair hydrogel containing V2CuS4 nanozyme The hydrogel prepared in Example 1 showed a hemolysis rate of <1.5% after co-culturing with red blood cells for 3 hours (ISO 10993-4 standard threshold ≤5%). Figure 5 The CCK-8 assay further showed that bone marrow mesenchymal stem cells (BMSCs) cultured in the composite hydrogel for 7 days had a survival rate of ≥90%, and alkaline phosphatase (ALP) activity increased by 1.5-fold, confirming its combination of biocompatibility and osteogenic induction function. The calculation method for CCK-8 cell viability is as follows: ; The ALP activity assay was performed as follows: cells were lysed, pNPP substrate (p-nitrophenyl phosphate) was added, the rate of yellow product formation was monitored at 405 nm, and the amount of enzyme required to hydrolyze 1 μmol of pNPP per minute was used as the activity unit.
[0063] This invention utilizes a hydrothermal method to construct V2CuS4 nanozyme ( Figure 1 The SEM morphology and EDS-mapping shown indicate uniformly shaped and elementally distributed flower-shaped particles, and the X-ray diffraction (XRD) pattern (…) Figure 2 The effectiveness of the synthesis method was confirmed in the in vitro hydrogen peroxide decomposition experiment. Figure 3 The V2CuS4 nanozyme exhibited significant peroxidase-like activity under physiological conditions. A photogelation cascade system composed of the V2CuS4 nanozyme, glucose oxidase (GOx), and methacrylamide-modified silk fibroin hydrogel achieved efficient degradation of glucose and oxidatively active species through enzymatic cascade reactions in a simulated diabetic microenvironment. Rheological tests verified the photogelation properties and extrudability of the hydrogel. Figure 4Hemolysis test () Figure 5 The study confirmed that the hemolysis rate of the material was <1.4% after 3 hours of co-culture with erythrocytes (ISO 10993-4 standard threshold ≤5%). Further CCK-8 assays showed that bone marrow mesenchymal stem cells (BMSCs) had a survival rate ≥90% after 7 days of culture in the composite hydrogel, and alkaline phosphatase (ALP) activity increased by 1.5 times, demonstrating its combination of biocompatibility and osteogenic induction function.
[0064] The application modes of the hydrogel for osteocartilage described in this invention are as follows: Figure 6 As shown; in a simulated diabetic microenvironment (glucose concentration 10mM, H2O2 concentration 100-500μM, Science Advances, 2021, 7, 35), the hydrogel prepared in this invention was tested using a kit (purchased from Nanjing Jiancheng) and found to have a scavenging rate of ≥95% for hydroxyl radicals and a scavenging rate of ≥85% for superoxide anions. This demonstrates that the hydrogel prepared in this invention has both good structural suitability and biological benefits.
[0065] In summary, the hydrogel obtained by this invention has good free radical scavenging efficacy, injectability, and biocompatibility, and also has efficient antioxidant and mineralization-promoting functions, making it applicable to osteochondral repair materials for diabetic patients.
[0066] The various embodiments of the present invention have been described above. These descriptions are exemplary and not exhaustive, nor are they limited to the disclosed embodiments. Many modifications and variations will be apparent to those skilled in the art without departing from the scope and spirit of the described embodiments. The terminology used herein is chosen to best explain the principles, practical application, or improvement of the technology in the market, or to enable others skilled in the art to understand the embodiments disclosed herein.
Claims
1. A method for preparing an active oxygen scavenging type osteochondral repair hydrogel for diabetes based on a hydrothermal method, characterized by, The method comprises the following steps: (1) mixing and dissolving copper salt, vanadium salt and sulfur source in water, and obtaining V2CuS4 nanoscale enzyme through hydrothermal reaction, centrifugation, washing and drying; (2) mixing glucose oxidase and V2CuS4 nanoscale enzyme uniformly to obtain an enzyme mixture, adding methyl acrylamidated silk fibroin to the enzyme mixture to obtain a mixed solution, adding a photoinitiator to the mixed solution to obtain a composite aqueous solution, and ultrasonic dispersing the composite aqueous solution to form an injectable three-dimensional network hydrogel with light-induced gelation characteristics. 2.The method for preparing active oxygen scavenging type bone and cartilage repair hydrogel for diabetes based on hydrothermal method according to claim 1, characterized in that, The copper salt in step (1) is one of copper chloride, copper nitrate and copper sulfate; the vanadium salt is one of vanadyl sulfate, sodium vanadate and vanadium oxide; and the sulfur source is one of sodium thiosulfate, thiourea and sulfur powder. 3.The method for preparing active oxygen scavenging type bone and cartilage repair hydrogel for diabetes based on hydrothermal method according to claim 1, characterized in that, In step (1), the stoichiometric ratio of Cu:V:S in the copper salt, vanadium salt and sulfur source is 1:2:4-8. 4.The method for preparing active oxygen scavenging type bone and cartilage repair hydrogel for diabetes according to claim 1, characterized in that, In step (1), the hydrothermal reaction condition is 120-180℃ constant temperature treatment for 12-24h. 5.The method for preparing active oxygen scavenging type bone and cartilage repair hydrogel for diabetes based on hydrothermal method according to claim 1, characterized in that, In step (1), the centrifugation parameters are 2000-6000rpm for 10-30 minutes; the washing is performed three times alternately using anhydrous ethanol and deionized water; the drying condition is vacuum-0.2 to-0.8MPa, 40-60℃, and the drying time is 6-18h. 6.The method for preparing active oxygen scavenging type bone and cartilage repair hydrogel for diabetes according to claim 1, wherein, The particle size of the V2CuS4 nanoscale enzyme in step (1) is 20-50 nm, and the specific surface area is ≥80 m 2 / g. 7.The method for preparing active oxygen scavenging type bone and cartilage repair hydrogel for diabetes according to claim 1, wherein, In step (2), the activity of the glucose oxidase is ≥150U / mg. 8.The method for preparing active oxygen scavenging type bone and cartilage repair hydrogel for diabetes according to claim 1, wherein, In step (2), the mass ratio of glucose oxidase and V2CuS4 nanoscale enzyme in the enzyme mixture is 1:1-5; the mass ratio of the enzyme mixture and methyl acrylamidated silk fibroin in the mixed solution is 1:80-100; and the mass percentage of the mixed solution and the photoinitiator in the composite aqueous solution is 1:0.05-0.2%. 9.The method for preparing active oxygen scavenging type bone and cartilage repair hydrogel for diabetes according to claim 1, wherein, The ultrasonic dispersion conditions in step (2) are 20-60 kHz, 30-70 W / cm 2 for 5-15 minutes at a mixing temperature of 15-30°C.
10. The active oxygen scavenging type diabetic osteochondral repair hydrogel prepared by the method of claims 1-9 is applied to a diabetic osteochondral repair material.
Citation Information
Patent Citations
3D printing enzyme-containing bioactive scaffold, preparation method and diabetic bone defect repair material
CN112451744A
Hedgehog flower-shaped nano-enzyme hydrogel for healing diabetic wounds
CN117159791A
Injectable nano-network gels for diabetes treatment
US20160067190A1
